MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 117 filers reported holding MIRUM PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $110,000 | +129.2% | 3,490 | +88.5% | 0.00% | – |
| Q2 2023 | $48,000 | +50.0% | 1,851 | +40.1% | 0.00% | – |
| Q1 2023 | $32,000 | -39.6% | 1,321 | -51.7% | 0.00% | – |
| Q4 2022 | $53,000 | +657.1% | 2,734 | +687.9% | 0.00% | – |
| Q3 2022 | $7,000 | +75.0% | 347 | +66.8% | 0.00% | – |
| Q2 2022 | $4,000 | -50.0% | 208 | -38.6% | 0.00% | – |
| Q1 2022 | $8,000 | -46.7% | 339 | -66.0% | 0.00% | – |
| Q4 2021 | $15,000 | +150.0% | 996 | +230.9% | 0.00% | – |
| Q3 2021 | $6,000 | -40.0% | 301 | -49.8% | 0.00% | – |
| Q2 2021 | $10,000 | +233.3% | 600 | +252.9% | 0.00% | – |
| Q1 2021 | $3,000 | – | 170 | +1114.3% | 0.00% | – |
| Q3 2020 | $0 | – | 14 | +7.7% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 13 | -95.1% | 0.00% | – |
| Q1 2020 | $4,000 | +100.0% | 267 | +238.0% | 0.00% | – |
| Q4 2019 | $2,000 | +100.0% | 79 | -20.2% | 0.00% | – |
| Q3 2019 | $1,000 | – | 99 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,566,912 | $62,278,000 | 4.80% |
| RiverVest Venture Management LLC | 1,921,118 | $33,543,000 | 3.68% |
| Burrage Capital Management LLC | 161,628 | $2,822,000 | 2.15% |
| AIGH Capital Management LLC | 274,583 | $4,794,000 | 1.95% |
| NEA Management Company, LLC | 4,187,801 | $73,119,000 | 1.93% |
| Novo Holdings A/S | 2,445,147 | $42,692,000 | 1.83% |
| Sio Capital Management, LLC | 494,743 | $8,638,000 | 1.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,448,912 | $60,218,000 | 1.19% |
| Rock Springs Capital Management LP | 1,496,525 | $26,129,000 | 0.55% |
| Prosight Management, LP | 60,250 | $1,052,000 | 0.49% |